October 17, 2019
Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period
Read More
September 14, 2019
A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
Read More
September 14, 2019
A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas
Read More
September 14, 2019
ALXN1210 (Ravulizumab) Versus Eculizumab in Complement Inhibitor Treatment-Naïve Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Read More
September 14, 2019
Clinical Trial of BCD-148 and Soliris® for the Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria
Read More
September 14, 2019
Study to Evaluate the Efficacy, Tolerability and Safety of Subcutaneous Human Immunoglobulin (Octanorm) in Patients With Primary Immunodeficiency Diseases
Read More
September 14, 2019
Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors
Read More
September 14, 2019
Phase 3 Study of Bulevirtide in Patients With CHD
Read More
September 14, 2019
Phase 2b Study of Bulevirtide (With Peginterferon Alfa-2a) in Patients With CHD
Read More
January 30, 2019
Safety and Efficacy Study of Sebelipase Alfa in Participants With Lysosomal Acid Lipase Deficiency
Read More
January 30, 2019
GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL)
Read More
January 30, 2019
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
Read More
Load More
X